Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Salomé Lalvée"'
Autor:
Simon Heeke, Véronique Hofman, Marius Ilié, Maryline Allegra, Virginie Lespinet, Olivier Bordone, Jonathan Benzaquen, Jacques Boutros, Michel Poudenx, Salomé Lalvée, Virginie Tanga, Carole Salacroup, Christelle Bonnetaud, Charles-Hugo Marquette, Paul Hofman
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-7 (2020)
Abstract Background NGS from plasma samples in non-squamous cell lung carcinoma (NSCC) can aid in the detection of actionable genomic alterations. However, the absolute clinical value of NGS in liquid biopsy (LB) made at baseline is currently uncerta
Externí odkaz:
https://doaj.org/article/d2ac3afd2f0e4adc9a4d53cea6320d3b
Autor:
Elodie Long-Mira, Alexandra Picard-Gauci, Sandra Lassalle, Véronique Hofman, Salomé Lalvée, Virginie Tanga, Katia Zahaf, Christelle Bonnetaud, Virginie Lespinet, Olivier Camuzard, Henri Montaudié, Gilles Poissonnet, Thierry Passeron, Marius Ilié, Paul Hofman
Publikováno v:
Diagnostics, Vol 12, Iss 3, p 751 (2022)
Testing for the BRAF mutation is mandatory for the management of patients with locally advanced or metastatic melanoma. Molecular analysis based on DNA sequencing remains the gold-standard method for the screening of the different BRAF mutations. The
Externí odkaz:
https://doaj.org/article/c45daa640a564eeda293675f6eb69b78
Autor:
Marius Ilié, Véronique Hofman, Christophe Bontoux, Samantha Goffinet, Jonathan Benzaquen, Simon Heeke, Jacques Boutros, Sandra Lassalle, Elodie Long-Mira, Katia Zahaf, Salomé Lalvée, Virginie Lespinet-Fabre, Olivier Bordone, Virginie Tanga, Abel Gómez-Caro, Charlotte Cohen, Jean-Philippe Berthet, Charles-Hugo Marquette, Paul Hofman
Publikováno v:
Lung Cancer. 181:107230
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c79d0f3fe7bbfe9af91f54473cfed8f
https://doi.org/10.1016/j.lungcan.2023.107230
https://doi.org/10.1016/j.lungcan.2023.107230
Autor:
Marius Ilié, Véronique Hofman, Christophe Bontoux, Simon Heeke, Virginie Lespinet-Fabre, Olivier Bordone, Sandra Lassalle, Salomé Lalvée, Virginie Tanga, Maryline Allegra, Myriam Salah, Doriane Bohly, Jonathan Benzaquen, Charles-Hugo Marquette, Elodie Long-Mira, Paul Hofman
Publikováno v:
Cancers; Volume 14; Issue 9; Pages: 2258
The number of genomic alterations required for targeted therapy of non-squamous non-small cell lung cancer (NS-NSCLC) patients has increased and become more complex these last few years. These molecular abnormalities lead to treatment that provides i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b172ee735d0ef25933a668531e1165de
Autor:
Simona Saccani, Salomé Lalvée, Charles-Hugo Marquette, Philippe Lenormand, Valérie Vouret-Craviari, Mathilde Butori, Simon Heeke, Véronique Hofman, Jonathan Benzaquen, Thierry Juhel, Jean-Philippe Berthet, Serena Janho Dit Hreich, Serge Bauwens, Paul Hofman, Sylvie Leroy
Publikováno v:
Theranostics
Rationale: The characterization of new theranostic biomarkers is crucial to improving the clinical outcome of patients with advanced lung cancer. Here, we aimed at characterizing the P2RX7 receptor, a positive modulator of the anti-tumor immune respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f088a009911f0abe445064371b1970a6
https://doi.org/10.7150/thno.48229
https://doi.org/10.7150/thno.48229
Autor:
Marius Ilié, Mélanie Beaulande, Elodie Long-Mira, Christophe Bontoux, Katia Zahaf, Salomé Lalvée, Marame Hamila, Jonathan Benzaquen, Charlotte Cohen, Jean-Philippe Berthet, Charles-Hugo Marquette, Sandra Lassalle, Véronique Hofman, Paul Hofman
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 166
The evaluation of an increasing number of diagnostic and predictive markers is playing a central role in precision thoracic oncology. Multiplex immunohistochemistry (mIHC), alongside next-generation sequencing, is ideally situated for this purpose an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8afc5d3919679eed727c2b7bdaa2da93
https://pubmed.ncbi.nlm.nih.gov/35134710
https://pubmed.ncbi.nlm.nih.gov/35134710
Autor:
Olivier Bordone, Carole Salacroup, Charles-Hugo Marquette, Jacques Boutros, Christelle Bonnetaud, Simon Heeke, Salomé Lalvée, Véronique Hofman, Paul Hofman, Michel Poudenx, Virginie Lespinet, Virginie Tanga, Maryline Allegra, Jonathan Benzaquen, Marius Ilie
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-7 (2020)
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-7 (2020)
Background NGS from plasma samples in non-squamous cell lung carcinoma (NSCC) can aid in the detection of actionable genomic alterations. However, the absolute clinical value of NGS in liquid biopsy (LB) made at baseline is currently uncertain. We as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf72844a1264933d23a4653d7b699c4
https://doi.org/10.1186/s12967-020-02259-2
https://doi.org/10.1186/s12967-020-02259-2
Autor:
Sandra, Lassalle, Véronique, Hofman, Simon, Heeke, Jonathan, Benzaquen, Elodie, Long, Michel, Poudenx, Elisabeth, Lantéri, Jacques, Boutros, Virginie, Tanga, Katia, Zahaf, Salomé, Lalvée, Virginie, Lespinet, Olivier, Bordone, Jean-Marc, Félix, Christelle, Bonnetaud, Charles, Marquette, Marius, Ilie, Paul, Hofman
Publikováno v:
Cancers
Background: Assessment of actionable EGFR mutations is mandatory for treatment-naïve advanced or metastatic non-squamous lung carcinoma (NSLC), but the results need to be obtained in less than 10 working days. For rapid EGFR testing, an EGFR-specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::79757b6b61a228c546f553d08eba49ad
https://pubmed.ncbi.nlm.nih.gov/32294880
https://pubmed.ncbi.nlm.nih.gov/32294880
Autor:
Charles-Hugo Marquette, Marius Ilie, Sylvie Leroy, Coraline Bence, Salomé Lalvée, Paul Hofman, Véronique Hofman, Charlotte Cohen, Simon Heeke, Florian Cattet, Jérôme Mouroux
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 56:980-989
Background: Circulating tumor cells (CTCs) hold potential for noninvasive diagnosis, prognosis and prediction testing in non-small cell lung cancer (NSCLC) patients. Minimizing degradation or loss of CTCs is pivotal for detection and profiling of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f5fc61d1c7906cc9b96c4e787e14930
https://doi.org/10.1515/cclm-2017-0764
https://doi.org/10.1515/cclm-2017-0764
Autor:
Alexandre Bozec, Patrick Brest, Marius Ilie, Thierry Juhel, Salomé Lalvée, Paul Hofman, Mathilde Butori-Pepino, Joséphine Zangari, Valérie Vouret-Craviari, Catherine Butori
Publikováno v:
Oncotarget
Oncotarget, 2017, 8 (34), ⟨10.18632/oncotarget.19170⟩
Oncotarget, Impact journals, 2017, 8 (34), ⟨10.18632/oncotarget.19170⟩
Oncotarget, 2017, 8 (34), ⟨10.18632/oncotarget.19170⟩
Oncotarget, Impact journals, 2017, 8 (34), ⟨10.18632/oncotarget.19170⟩
MicroRNAs (miRs) participate in tumor growth and dissemination by regulating expression of various target genes. MiR-223-3p is suspected of being involved in head and neck squamous cell carcinoma (HNSCC) growth although its precise role has not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e82e285efa8374a4497b3a416f9a5b75
https://doi.org/10.18632/oncotarget.19170
https://doi.org/10.18632/oncotarget.19170